Search PubMed⌕ Search

Biomedical subjects

R Prieto

Publications and source records attributed to R Prieto.

At least 37 records · Page 2Linked to original sources

Dietary effects upon calcium oxalate urolithiasis risk.

An animal model involving rats fed with different diets (high protein, high carbohydrate, high lipid, high fiber and control balanced diet) was used to evaluate the dietary effects on the main oxalocalcic urolithogenic parameters. It was found that the inhibitory factors that prevent calcium oxalate stone formation (citrate and magnesium) were clearly more favorable in the group of rats fed with a balanced diet. However, factors favouring the heterogeneous calcium phosphate nucleation were also found in the balanced diet. On the other hand, factors facilitating the heterogeneous uric acid nucleation were found in rats treated with high protein, high lipid, high carbohydrate and high fiber diets. In conclusion it seems that the balanced diet appears to be the less lithogenic one.

Animals↗

Effect of "Rosa Canina" infusion and magnesium on the urinary risk factors of calcium oxalate urolithiasis.

The effects on the calcium oxalate urolithiasis urinary risk factors of "Rosa Canina", in herb infusion form, and magnesium chloride have been studied using female Wistar rats under balanced dietary conditions. No significant effects on the volume of liquids drunk or on creatinine, phosphate, and oxalate urinary concentrations and excretions were observed. The herb infusion did not cause any diuretic effect. Calciuria decreased and citraturia increased when taking the herb infusion, and vice versa when taking magnesium chloride. Magnesium chloride decreased the urinary pH value, but this effect was not observed when magnesium chloride was administered with herb infusion. In conclusion, the same beneficial effects of the studied infusion herb on calcium oxalate urolithiasis urinary risk factors can be clearly detected. An interesting fact is that it seems that some possible effects depend on dietary components, thus, i.e., an increase in the urinary pH was only detected when the intake of the herb infusion was studied in a magnesium chloride-supplemented diet.

Animals↗

nit 7: A New Locus for Molybdopterin Cofactor Biosynthesis in the Green Alga Chlamydomonas reinhardtii.

Two new nitrate reductase-deficient mutants from Chlamydomonas reinhardtii have been genetically and biochemically characterized. Both H1 and F23 mutants carry single recessive allelic mutations that map at a new locus designated nit-7. This locus is unlinked to the other six nit loci related to the nitrate assimilation pathway in C. reinhardtii. Both mutant alleles H1 and F23 lack an active molybdopterin cofactor, the activity of which is restored neither in vitro nor in vivo by high concentrations of molybdate. Nitrate reductase subunits in these mutants seem to assemble, although not in a stable form, in a high molecular weight complex and, as in other molybdenum cofactor-defective mutants of C. reinhardtii, they cannot reconstitute nitrate reductase activity with an active molybdenum cofactor source from extracts of ammonium-grown cells. The results suggest that nit-7 mutants are defective in molybdopterin biosynthesis. They do produce some precursor(s) that are capable of binding to nitrate reductase subunits.

Journal Article↗

An animal model to study the effects of diet on risk factors of calcium stone formation.

The effects of diet on the formation of calcium oxalate stones were studied in 150-day-old rats by measuring the diuresis, pH, and urinary and blood concentrations of promoting and inhibitory substances. An increase in phosphate (promoting) and magnesium (inhibiting), and a decrease in citrate (inhibiting) and pH were found in the urine of rats fed with a high protein diet. No differences were observed in the plasma concentrations of calcium, magnesium, and phosphate. These results confirm epidemiological and clinical studies in humans that have shown that any diet rich in protein can change the concentrations of these substances in urine.

Animals↗

In vitro comparison of the antacid potencies of almagate in tablets and suspension with those of other commercially available antacid preparations.

Almagate (hydrated aluminium-magnesium hydroxycarbonate, Al2Mg6(OH)14(CO3)2 X 4 H2O, Almax) in the form of tablets and suspension was compared with other commercially available antacid preparations in a battery of tests designed to evaluate antacid activity and related properties. The evaluation of an antacid should take into account, in addition to total acid neutralising capacity, neutralising capacity under dynamic conditions related to in vivo events, bioavailability, speed of action, lack of possible rebound effect and low sodium content. When these considerations are taken into account Almax tablets and suspension can be classified as highly effective antacids retaining a high proportion of their total neutralising capacity under simulated in vivo conditions. As in the case of the active principle, almagate, the enzyme pepsin has a positive effect on acid neutralising activity.

Aluminum Hydroxide↗

[Venlafaxine titration dosage in depressive in-patients. A series of cases].

This series of patients was gathered to assess the use of last and slow titration dosage of venlafaxine in in-patients with major depression and to evaluate the action onset. An observational open study was performed in 3 centers in 18 in-patients. Nine patients were included in fast titration dosage group (FT) and 9 in slow titration dosage group (ST). As results, it was found that the FT group showed faster improvement than the ST group in HAM-D score. This improvement was sustained to the final visit, with a lower score in the FT group (6.75) than the ST group (10.67). MADRS scores up to the 15th visit were similar; however, the score was lower in the ST group on the 20th visit. Improvement was sustained to the final visit, the FT group score being lower (6.50) than the ST group score (14). CGI - i mprovement and CGI-seve rity scores we re similar to the above mentioned results. The most common events in both groups were considered mild. The data of these patients show faster response to antidepressant therapy with faster titration dosage, with maintenance of the molecule's tolerability profile.

Adolescent↗

[Brain aneurysms: an infrequent cause of transient ischemic stroke].

INTRODUCTION: Ischemic symptomatology related to the presence of saccular brain aneurysms is infrequent, and this makes it difficult to reach a widespread agreement about the most suitable treatment. CASE REPORT: A 17-year-old male with symptoms of little stroke produced by distal embolisation of an aneurysm in the middle cerebral artery. The patient was treated by endovascular aneurysm exclusion. CONCLUSIONS: In patients with no other identifiable cause of ischemic attacks, the possible presence of a brain aneurysm must be taken into account. First choice treatment is the obliteration of the aneurysm using endovascular techniques. If the approach to the aneurysm (either endovascular or surgical) entails a high risk for the patient, another possibility is to use antiplatelet drugs.

Adolescent↗

[Effectiveness of venlafaxine in the treatment of alcohol dependence with comorbid depression].

INTRODUCTION: There are no conclusive data on the effectiveness of antidepressant drugs in the treatment of comorbid cases of alcohol dependence and depression. OBJECTIVES: To determine the effectiveness of venlafaxine on depression and on severity (need of treatment) of alcohol dependence and related problems. METHODS: Observational, open-label, multicenter, 24-week follow-up study. PATIENTS: 90 outpatients with diagnosis of alcohol dependence and associated major depression disorder (DSMIV criteria). OUTCOMES MEASURES: the Hamilton Rating Scale for Depression (HAM-D17), European Addiction Severity Index (EuropASI) and Clinical Global Impression, severity and improvement subscales, (CGI-S and CGI-I). Evaluations were performed at baseline and at weeks 2, 4, 8 and 24. RESULTS: Mean age 44.94+/-9.74 years; 73.3 % man. HAM-D17 mean scores significantly decreased from baseline (24.85+/-5.94) to week 24 (5.976+/-4.68) and at each of the follow-up visits vs previous visit (p < 0.0005). Significant decreases from baseline to week 24 were obtained in four areas of EuropASI: medical status (2.12+/-2.45 to 1.07+/-1.68), alcohol use (5.29+/-2.24 to 3.04+/-2.35), family/ social relationships (3.68+/-2.36 to 1.71+/-2.06) and psychiatric status (5.61+/-1.81 to 2.67+/-2.03). Tolerance was excellent or good in 76.7% of the patients. CONCLUSIONS: Venlafaxine demonstrated to be effective in the treatment of depressive alcoholic patients. Furthermore, it seems to be useful to decrease the severity of problems related with the alcohol use.

Adult↗

Psychometric properties of the Spanish version of the screening scale for DSM-IV Generalized Anxiety Disorder of Carroll and Davidson.

INTRODUCTION: The aim was to validate the Spanish version of the screening scale for DSM-IV General Anxiety Disorder of Carroll and Davidson for use in research and clinical practice in Spain for screening and assessing specific anxiety symptoms of patients with Generalized Anxiety Disorder (GAD). METHODS: Observational, prospective, multisite, study comparing between patients with DSM-IV diagnosis of GAD (group A), starting or switching treatment (group A1) or stable patients (group A2), followed-up for 6 months (group A1) or 2 weeks (group A2) versus healthy control subjects (group B), assessed in a single visit. RESULTS: Among 223 valuable subjects the scale showed: a) adequate feasibility with a mean time of administration: 6.53 and 4.49 min (TD: 5.48 and 3.56) in groups A and B, and percentage of patients without response <5 %; b) adequate reliability (Kuder-Richardson coefficient: 0.85 and 0.79 in groups A1 and A2, and CCI coefficient: 0.89 in group A2); c) adequate validity, showing capability for discriminating between patients and controls, with area under curve AUC: 0.9713 (IC 95 %: 0.9510-0.9917), and obtaining a high correlation with HARS (r=0.88) and CGI-G (r=0.87) scales, y d) adequate sensitivity to clinical changes from start and end of treatment (SES: -1.6, -3.1 and -3.8 after 1, 3 and 6 months), spite of the high percentage of patients with highest score in group A1 (38.6 %). CONCLUSION: The Spanish version of the screening scale for DSM-IV GAD showed adequate psychometric properties for use in research and clinical practice in Spain as well as an screening as evaluative measure for patients with GAD, spite of the ceiling effect showed in severe patients.

Adult↗